Sorrento Therapeutics stock trades at USD 0.0008 with USD 0.4 million cap
Published on 10/04/2026 at 10:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sorrento Therapeutics (ISIN US83587F2020) was last at USD 0.0008 on OTC Markets on October 2, 2026, with a market capitalization of USD 0.4 million. The latest legal development came on September 29, 2026, when a bankruptcy appeal notice recorded a voluntary dismissal. For investors, the stock's extreme distance from its yearly high makes the legal record more relevant than a conventional earnings narrative.
The stock sits near its yearly floor
The quote matched the day's USD 0.0008 high and low and stood 98.41 percent below the 52-week high of USD 0.0502. The same market snapshot placed the 52-week low at USD 0.0001, so the latest price was 700.00 percent above that low.
Investing.com identifies SRNE as an OTC Markets security in USD and assigns the company the ISIN US83587F2020. Its quote page lists a previous close of USD 0.0008 and a daily change of 0.00 percent for the October 2, 2026 snapshot.
Bankruptcy appeal adds legal context
Law360 reported a notice filed on September 28, 2026 and entered on September 29, 2026 concerning the voluntary dismissal of an individual bankruptcy appeal. The docket places the development within Sorrento's continuing post-bankruptcy legal history.
Investing.com says Sorrento filed for Chapter 11 reorganization on February 13, 2023, and that its liquidation plan received approval on November 30, 2023. That history frames the September 2026 docket activity as a legal checkpoint rather than a new operating result.
Biotech programs define the company
Sorrento's business profile spans cancer, chronic pain and infectious diseases, with programs involving antibody therapies, cellular therapies and drug-delivery technologies. The company has also been associated with RTX, the Sofusa platform and SEMDEXA, while its operations have included Sorrento Therapeutics and Scilex segments, according to Investing.com.
SRNE remains a microcap quote
Sorrento Therapeutics stock was last at USD 0.0008 on OTC Markets on October 2, 2026, with a 0.00 percent daily change and a market capitalization of USD 0.4 million. The next earnings date shown by the quote page is November 6, 2026.
Sorrento Therapeutics stock data
- Company: Sorrento Therapeutics, Inc.
- ISIN: US83587F2020
- Ticker: SRNE
- Trading venue: OTC Markets
- Price (as of October 2, 2026): USD 0.0008
- Market capitalization: USD 0.4 million (as of October 2, 2026)
- 52-week range: USD 0.0001-0.0502 (as of October 2, 2026)
- Sector / Industry: Healthcare / Biotechnology
- Next earnings date: November 6, 2026
